By Sarah Trowbridge Users asked, and YouScript Personalized Prescribing Software delivered. The end of July saw the launch of YouScript 8.0, which brings new features and improvements to software functionality,…
Read More
As a 12 year-old-boy in India, Ranjit Thirumaran, M.Pharm, PhD, saw the toll adverse drug reactions can take firsthand. Following hospitalization after a minor accident, his uncle suddenly died, likely…
Read More
Update: The results of this research are in! Find out more here. How can pharmacogenetic testing improve care for elderly patients taking multiple medications? Genelex is trying to find out.…
Read More
Recent research sponsored by Genelex and undertaken by University of Utah researchers has been recognized at the national Academy of Managed Care Pharmacy (AMCP) conference. The research shows that as many…
Read More
The year 2014 ended on a positive note for Genelex, with multiple publications bestowing the company with six awards or accolades for business growth and technological advancement. In November, Inc. magazine included…
Read More
A national business magazine has named Genelex the 10th fastest-growing private company in Seattle. In the fifth such listing for Genelex this year, Inc. magazine has included the Seattle-based company…
Read More
For the third time since Genelex was founded, the Seattle-based company leading the way in DNA sensitivity testing to help combat adverse drug events has been named one of Washington’s…
Read More
Genelex’s progress toward eliminating adverse drug events has been honored by Seattle Business magazine with a 2014 Tech Impact Award. At the September 18 awards event, Genelex was given the…
Read More
